Canadian Healthcare Technology: Knee assessment device available in Canada and US

MONTREAL – Emovi, Inc. announced the U.S. launch of KneeKG, the first in-clinic device that meets the global need for measuring knee function with objective and quantifiable data associated with mechanical knee markers and functional deficiencies.

KneeKG is the first device to enable doctors to accurately assess patients’ knees in 3D while the patient is moving and weight-bearing. In contrast to static information from X-ray and magnetic resonance imaging (MRI), KneeKG quickly identifies the functional causes linked to knee pain, allowing doctors to better target treatments instead of the current process of elimination method, revolutionizing current knee assessment.

In April, the Nova Scotia Health Authority (NSHA) announced that it is working to support the commercialization of a provincially implemented software platform and assessment tools that will improve orthopaedic wait times and patient outcomes across Nova Scotia and that Emovi’s KneeKG is a key component of the solution….

Read article :

Contact us